» Articles » PMID: 12114043

How Practical Are Recommendations for Dietary Control in Phenylketonuria?

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2002 Jul 13
PMID 12114043
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with phenylketonuria, blood phenylalanine concentration during childhood is the major determinant of cognitive outcome. Guidelines provide age-related recommendations for treatment. To ascertain the extent to which these aims are achievable, we audited results from four centres for the years 1994-2000. The median proportion of samples with phenylalanine concentrations above those recommended was less than 30% for those younger than age 10 years but almost 80% for those aged 15 years and older. Similarly, the median frequency of blood sampling, expressed as a proportion of that recommended, was more than 80% for patients younger than 10 years but less than 50% by age 15 years. Our results indicate the difficulty of maintaining control in phenylketonuria, especially in older rather than younger children.

Citing Articles

Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational study.

Feillet F, Arnoux J, Delgado M, Burlina A, Chabrol B, Kucuksayrac E J Inherit Metab Dis. 2024; 48(1):e12796.

PMID: 39237321 PMC: 11667744. DOI: 10.1002/jimd.12796.


Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?.

Pinto A, Ahring K, Almeida M, Ashmore C, Belanger-Quintana A, Burlina A Nutrients. 2024; 16(13).

PMID: 38999811 PMC: 11243388. DOI: 10.3390/nu16132064.


Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary Adherence.

Gonzalez-Lamuno D, Morencos C, Arrieta F, Venegas E, Vicente-Rodriguez G, Casajus J Nutrients. 2024; 16(5).

PMID: 38474766 PMC: 10933964. DOI: 10.3390/nu16050639.


Adult PKU Clinics in the UK-Users' Experiences and Perspectives.

Ilgaz F, Ford S, ODriscoll M, MacDonald A Nutrients. 2023; 15(20).

PMID: 37892429 PMC: 10610305. DOI: 10.3390/nu15204352.


Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia.

Delsoglio M, Capener R, MacDonald A, Daly A, Ashmore C, Donald S Nutrients. 2023; 15(16).

PMID: 37630788 PMC: 10459832. DOI: 10.3390/nu15163598.